advertisement
PURPOSE: Glaucoma is characterized by optic nerve damage and retinal ganglion cell loss. The glycoprotein neuromedin B-associated () gene is well-known to be involved in the glaucoma disease process. The purpose of this study is to identify a downstream gene through which affects the glaucoma phenotypes using a systems genetics approach. METHODS: Retinal gene expression data for the BXD recombinant inbred (RI) strains (n=75) have previously been generated in our laboratory for a glaucoma study, and these data were used for genetic and bioinformatics analysis. Expression quantitative trait locus (eQTL) mapping and genetic correlation methods were used to identify a gene downstream of . Gene-set enrichment analysis was used to evaluate gene function and to construct coexpression networks. RESULTS: The level of expression is associated with a highly statistically significant -eQTL. Stanniocalcin 1 () has a significant trans-eQTL mapping to the locus. The expression of and is highly correlated in the retina and other tissues, as well as with glaucoma-related phenotypes. Gene Ontology and pathway analysis showed that and its covariates are highly associated with apoptosis, oxidative stress, and mitochondrial activity. A generated gene network indicated that and are directly connected to and interact with other genes with similar biologic functions. CONCLUSIONS: These results suggest that may be a downstream candidate of , and that both genes interact with other genes in a network to develop glaucoma pathogenesis through mechanisms such as apoptosis and oxidative stress.
Department of Ophthalmology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
3.5 Molecular biology incl. SiRNA (Part of: 3 Laboratory methods)
3.4.2 Gene studies (Part of: 3 Laboratory methods > 3.4 Molecular genetics)